US Patent 11254651 Histone methyltransferase inhibitors
Patent 11254651 was granted and assigned to Global Blood Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 15, 2017
Date of Patent
February 22, 2022
Patent Applicant
Patent Application Number
16076307
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11254651 Histone methyltransferase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.